Literature DB >> 17312143

Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity.

Tomofumi Uto1, Xin Wang, Katsuaki Sato, Misako Haraguchi, Takami Akagi, Mitsuru Akashi, Masanori Baba.   

Abstract

Nanoparticles are considered to be efficient tools for inducing potent immune responses by an Ag carrier. In this study, we examined the effect of Ag-carrying biodegradable poly(gamma-glutamic acid) (gamma-PGA) nanoparticles (NPs) on the induction of immune responses in mice. The NPs were efficiently taken up by dendritic cells (DCs) and subsequently localized in the lysosomal compartments. gamma-PGA NPs strongly induced cytokine production, up-regulation of costimulatory molecules, and the enhancement of T cell stimulatory capacity in DCs. These maturational changes of DCs involved the MyD88-mediated NF-kappaB signaling pathway. In vivo, gamma-PGA NPs were preferentially internalized by APCs (DCs and macrophages) and induced the production of IL-12p40 and IL-6. The immunization of mice with OVA-carrying NPs induced Ag-specific CTL activity and Ag-specific production of IFN-gamma in splenocytes as well as potent production of Ag-specific IgG1 and IgG2a Abs in serum. Furthermore, immunization with NPs carrying a CD8(+) T cell epitope peptide of Listeria monocytogenes significantly protected the infected mice from death. These results suggest that Ag-carrying gamma-PGA NPs are capable of inducing strong cellular and humoral immune responses and might be potentially useful as effective vaccine adjuvants for the therapy of infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312143     DOI: 10.4049/jimmunol.178.5.2979

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A.

Authors:  Tae-Young Lee; Doo-Jin Kim; Ji-Na Won; Il-Han Lee; Moon-Hee Sung; Haryoung Poo
Journal:  J Invest Dermatol       Date:  2013-09-11       Impact factor: 8.551

Review 2.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

3.  Cheonggukjang ethanol extracts inhibit a murine allergic asthma via suppression of mast cell-dependent anaphylactic reactions.

Authors:  Min-Jung Bae; Hee Soon Shin; Hye-Jeong See; Ok Hee Chai; Dong-Hwa Shon
Journal:  J Med Food       Date:  2014-01       Impact factor: 2.786

Review 4.  Applications and perspectives of nanomaterials in novel vaccine development.

Authors:  Yingbin Shen; Tianyao Hao; Shiyi Ou; Churan Hu; Long Chen
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

5.  Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo.

Authors:  Tomofumi Uto; Masaaki Toyama; Yosuke Nishi; Takami Akagi; Fumiaki Shima; Mitsuru Akashi; Masanori Baba
Journal:  Results Immunol       Date:  2012-12-03

6.  Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect.

Authors:  Tae-Young Lee; Yang-Hyun Kim; Sun-Woo Yoon; Jai-Chul Choi; Jai-Myung Yang; Chul-Joong Kim; John T Schiller; Moon-Hee Sung; Haryoung Poo
Journal:  Cancer Immunol Immunother       Date:  2009-03-18       Impact factor: 6.968

Review 7.  Targeting TLR/IL-1R signalling in human diseases.

Authors:  Maria Loiarro; Vito Ruggiero; Claudio Sette
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

8.  Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.

Authors:  Thomas J Powell; Jie Tang; Mary E Derome; Robert A Mitchell; Andrea Jacobs; Yanhong Deng; Naveen Palath; Edwin Cardenas; James G Boyd; Elizabeth Nardin
Journal:  Vaccine       Date:  2013-02-26       Impact factor: 3.641

9.  Poly-gamma-glutamic acid from Bacillus subtilis upregulates pro-inflammatory cytokines while inhibiting NLRP3, NLRC4 and AIM2 inflammasome activation.

Authors:  Huijeong Ahn; Seung Goo Kang; Sung-Il Yoon; Pyeung-Hyeun Kim; Doo Kim; Geun-Shik Lee
Journal:  Cell Mol Immunol       Date:  2016-05-02       Impact factor: 11.530

Review 10.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.